PT3180329T - Triazóis como inibidores do recetor nr2b - Google Patents
Triazóis como inibidores do recetor nr2bInfo
- Publication number
- PT3180329T PT3180329T PT157777541T PT15777754T PT3180329T PT 3180329 T PT3180329 T PT 3180329T PT 157777541 T PT157777541 T PT 157777541T PT 15777754 T PT15777754 T PT 15777754T PT 3180329 T PT3180329 T PT 3180329T
- Authority
- PT
- Portugal
- Prior art keywords
- triazoles
- receptor inhibitors
- nr2b receptor
- nr2b
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462037831P | 2014-08-15 | 2014-08-15 | |
US201562146656P | 2015-04-13 | 2015-04-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3180329T true PT3180329T (pt) | 2020-06-08 |
Family
ID=54266608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT157777541T PT3180329T (pt) | 2014-08-15 | 2015-08-14 | Triazóis como inibidores do recetor nr2b |
Country Status (9)
Country | Link |
---|---|
US (2) | US9981950B2 (pt) |
EP (1) | EP3180329B1 (pt) |
JP (1) | JP6605020B2 (pt) |
DK (1) | DK3180329T3 (pt) |
ES (1) | ES2791186T3 (pt) |
HU (1) | HUE049277T2 (pt) |
PL (1) | PL3180329T3 (pt) |
PT (1) | PT3180329T (pt) |
WO (1) | WO2016025917A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016025918A1 (en) | 2014-08-15 | 2016-02-18 | Janssen Pharmaceuticals, Inc. | Pyrazoles |
US9981950B2 (en) | 2014-08-15 | 2018-05-29 | Janssen Pharmaceuticals, Inc. | Triazoles as NR2B receptor inhibitors |
HUE047460T2 (hu) | 2015-07-09 | 2020-04-28 | Janssen Pharmaceutica Nv | Szubsztituált 4-azaindolok és ezek alkalmazása mint GLUN2B receptor modulátorok |
AU2017217542B2 (en) * | 2016-02-10 | 2021-06-03 | Janssen Pharmaceutica Nv | Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators |
TW201819376A (zh) | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途 |
JP7208139B2 (ja) * | 2016-12-14 | 2023-01-18 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 双極性障害の予防、軽減又は治療のためのカルバメート化合物の使用 |
JP7346441B2 (ja) | 2018-04-04 | 2023-09-19 | ヤンセン ファーマシューティカ エヌ.ベー. | 置換ピリジン及びピリミジン並びにglun2b受容体調節物質としてのそれらの使用 |
CR20210580A (es) | 2019-06-14 | 2022-01-31 | Janssen Pharmaceutica Nv | Amidas depirazol-piridina sustituidos y su uso como moduladores del receptor glun2b |
WO2020249785A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulators |
US20220324860A1 (en) | 2019-06-14 | 2022-10-13 | Janssen Pharmaceutica Nv | SUBSTITUTED PYRAZOLO[4,3-b]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS |
CA3143105A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | Substituted pyrazolo-pyrazines and their use as glun2b receptor modulators |
BR112021025132A2 (pt) | 2019-06-14 | 2022-01-25 | Janssen Pharmaceutica Nv | Carbamatos de piridina e seu uso como moduladores do receptor glun2b |
US11459336B2 (en) | 2019-06-14 | 2022-10-04 | Janssen Pharmaceutica Nv | Pyrazine carbamates and their use as GluN2B receptor modulators |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610723B2 (en) * | 2001-01-29 | 2003-08-26 | Hoffmann-La Roche Inc. | Imidazole derivatives |
WO2003082868A1 (en) | 2002-03-28 | 2003-10-09 | Eisai Co., Ltd. | 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
US7005432B2 (en) * | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
BRPI0507501A (pt) | 2004-02-18 | 2007-06-26 | Astrazeneca Ab | composto, composição farmacêutica, uso do composto, método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5 |
US7807704B2 (en) | 2006-03-30 | 2010-10-05 | Chemocentryx, Inc. | Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 |
PE20090717A1 (es) | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
EP2167464B1 (en) | 2007-05-25 | 2014-12-03 | AbbVie Deutschland GmbH & Co KG | Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) |
EA201070323A1 (ru) | 2007-08-30 | 2010-10-29 | Такеда Фармасьютикал Компани Лимитед | Замещенное производное пиразола |
WO2009058261A1 (en) | 2007-10-31 | 2009-05-07 | Merck & Co., Inc. | Modulation of sleep with nr2b receptor antagonists |
EP2254580A1 (en) | 2008-03-27 | 2010-12-01 | EVOTEC Neurosciences GmbH | Methods for treating disorders using nmda nr2b-subtype selective antagonist |
EP2308877B1 (en) | 2008-08-05 | 2014-01-22 | Daiichi Sankyo Company, Limited | Imidazopyridin-2-one derivatives |
US9643922B2 (en) * | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
ES2466341T3 (es) | 2008-10-16 | 2014-06-10 | Janssen Pharmaceuticals, Inc. | Derivados de indol y benzomorfolina como moduladores de receptores de glutamato metabotrópicos |
AU2009324894B2 (en) | 2008-11-25 | 2015-04-09 | University Of Rochester | MLK inhibitors and methods of use |
EP2408753A4 (en) * | 2009-03-20 | 2012-11-07 | Univ Brandeis | COMPOUNDS AND METHOD FOR THE TREATMENT OF MICROBIAL STOMACH DARM INFECTIONS IN MAMMALS |
US8765784B2 (en) | 2010-06-09 | 2014-07-01 | Merck Sharp & Dohme Corp. | Positive allosteric modulators of MGLUR2 |
US9434743B2 (en) | 2012-03-02 | 2016-09-06 | Takeda Pharmaceutical Company Limited | Indazole derivatives |
WO2014124651A1 (en) | 2013-02-15 | 2014-08-21 | Københavns Universitet | Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists |
BR112015021549A2 (pt) | 2013-03-13 | 2017-07-18 | Abbvie Inc | inibidores de piridina cinase cdk9 |
US9981950B2 (en) | 2014-08-15 | 2018-05-29 | Janssen Pharmaceuticals, Inc. | Triazoles as NR2B receptor inhibitors |
WO2016025918A1 (en) | 2014-08-15 | 2016-02-18 | Janssen Pharmaceuticals, Inc. | Pyrazoles |
HUE047460T2 (hu) | 2015-07-09 | 2020-04-28 | Janssen Pharmaceutica Nv | Szubsztituált 4-azaindolok és ezek alkalmazása mint GLUN2B receptor modulátorok |
AU2017217542B2 (en) | 2016-02-10 | 2021-06-03 | Janssen Pharmaceutica Nv | Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators |
TW201819376A (zh) | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途 |
-
2015
- 2015-08-14 US US15/503,864 patent/US9981950B2/en active Active
- 2015-08-14 PT PT157777541T patent/PT3180329T/pt unknown
- 2015-08-14 DK DK15777754.1T patent/DK3180329T3/da active
- 2015-08-14 ES ES15777754T patent/ES2791186T3/es active Active
- 2015-08-14 JP JP2017508504A patent/JP6605020B2/ja active Active
- 2015-08-14 HU HUE15777754A patent/HUE049277T2/hu unknown
- 2015-08-14 PL PL15777754T patent/PL3180329T3/pl unknown
- 2015-08-14 EP EP15777754.1A patent/EP3180329B1/en active Active
- 2015-08-14 WO PCT/US2015/045412 patent/WO2016025917A1/en active Application Filing
-
2018
- 2018-04-27 US US15/964,794 patent/US10323021B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3180329A1 (en) | 2017-06-21 |
JP2017524019A (ja) | 2017-08-24 |
JP6605020B2 (ja) | 2019-11-13 |
EP3180329B1 (en) | 2020-03-18 |
US9981950B2 (en) | 2018-05-29 |
ES2791186T3 (es) | 2020-11-03 |
US20180282305A1 (en) | 2018-10-04 |
US10323021B2 (en) | 2019-06-18 |
DK3180329T3 (da) | 2020-04-06 |
US20170226087A1 (en) | 2017-08-10 |
HUE049277T2 (hu) | 2020-09-28 |
WO2016025917A1 (en) | 2016-02-18 |
PL3180329T3 (pl) | 2020-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287113A (en) | smyd inhibitors | |
HK1231480A1 (zh) | 作為 抑制劑的吲唑化合物 | |
IL251071A0 (en) | Benzyl-substituted indazoles as bub1 inhibitors | |
IL251584B (en) | Dihydropyrrolopyridines ror–gamma inhibitors | |
IL246785A0 (en) | Benzimidazole-2-amines as midh1 inhibitors | |
IL246902B (en) | Dihydropyrrolopyridine ror–gamma inhibitors | |
PT3180329T (pt) | Triazóis como inibidores do recetor nr2b | |
HK1226398A1 (zh) | 作為midh1抑制劑的苯並咪唑-2-胺 | |
GB201411344D0 (en) | Cloning | |
AP2016009496A0 (en) | Substituted spirocydic inhibitors of autotaxin | |
IL248895A0 (en) | Phosphatidylinositol 3-kinase inhibitors | |
HUE036810T2 (hu) | Elrendezés jármû ajtajának nyitására | |
PL3204186T3 (pl) | Jednostka doprowadzająca | |
PL3122667T3 (pl) | Jednostka podająca | |
IL250306A0 (en) | indazoles | |
PL3122664T3 (pl) | Jednostka doprowadzająca | |
GB201405651D0 (en) | Delivering an action | |
PL3122666T3 (pl) | Podający zespół | |
AU5514P (en) | FT01 Trachelospermum asiaticum | |
GB201418154D0 (en) | Inhibitors | |
AU2014301V (en) | SJ01 Trachelospermum asiaticum | |
HK1198459A2 (en) | Connecting apparatus for construction | |
GB201405343D0 (en) | Feed unit |